Company Information
HKD
14.06
- (-3.4%)
SEHK:02269, WUXI BIOLOGICS (CAYMAN) INC.
Industry: Biotechnology
End of Day: 17 May 2024 GMT+8
WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.
Address
No. 108, Meiliang Road
Mashan Binhu District
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Dr. Ning Zhao,PhD
Director
Mr. William Robert Keller
Director
Mr. Yanling Cao
Director
Mr. Kenneth Walton Hitchner, III
Director
Dr. Chen Zhisheng
CEO/Director
Dr. Yibing Wu, PhD
Director
Dr. Li Ge
Chairman of the Board/Director
Dr. Weichang Zhou
Chief Technology Officer/Director/President, Divisional
Ownership
Institution Holdings
BOCI-Prudential Asset Management
1,443,000 (0.069%)
BEA Union Investment Management Ltd
1,279,000 (0.061%)
Sumitomo Mitsui Trust Asset Management Co., Ltd.
643,000 (0.031%)
BlackRock Inc
494,109 (0.024%)
Amundi Hong Kong Ltd
434,000 (0.021%)
Nikko Asset Management Co Ltd
391,500 (0.019%)
Nomura Asset Management Co Ltd
369,500 (0.018%)
Asset Management One Co., Ltd.
295,500 (0.014%)
RHB Islamic International Asset Management Berhad
292,500 (0.014%)
Harvest Global Investments Limited
266,500 (0.013%)
Funds Holdings
BEA Union Investment Greater China Gr
958,500 (0.046%)
SMTAM Emerging Equity Index Mother
628,000 (0.030%)
BOCHK HK Equity
525,500 (0.025%)
RHB Shariah China Focus Fund
292,500 (0.014%)
SMDS Emerging Equity Index Mother
135,000 (0.006%)
Amundi HK Growth
37,000 (0.002%)
Amundi HK Defensive Balanced Fund
34,000 (0.002%)
Nissay Emerg Equity Index Mother Fund
32,500 (0.002%)
Lazard Emerging Asia Opportunities ADR
15,163 (0.001%)
QRG QP: Sustainable EM ADR ESG
860 (0.000%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
